Companies/Praxsyn Corporation

Company profile

Praxsyn Corporation

OTC: PXYN · Healthcare · Medical - Pharmaceuticals

PublicHQ Las Vegas, ILCIK 0001346973Reports USD

#394 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ 11GM —SS 44

v0.1 · 25/100 weight · pillars only

↑ operating margin, 3-yr revenue growth · ↓ return on equity, disclosure history

Methodology →

Revenue TTM

$20.5M

Rev growth YoY (TTM)

-69.0%

Net income (FY)

-$12.4M

Employees

Market cap

$6.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$66.6M$66.6M2014

Net income-$12.4M-$12.4M2014

Operating income$26.1M$26.1M2014

Total assets$16.7M$16.7M2014

Liabilities$15.1M$15.1M2014

Equity$1.6M$1.6M2014

Revenue trend

FY2011 – FY2014 · USD

$628.8k

FY11

$872.6k

FY11

$1.3M

FY11

$1.5M

FY11

$1.6M

FY11

$7.0M

FY14

$66.6M

FY14

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Praxsyn Corporation booked $66.6M in FY2014 revenue, growing 853% year over year — faster than 96% of Healthcare companies we track, at a -18.6% net margin.

Peers · Healthcare

Bloomios, Inc.——PAO Group, Inc.——CEN Biotech, Inc.——NovAccess Global Inc.——

Key facts

CEOSean Daly

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersLas Vegas, IL

ExchangeOTC: PXYN

Employees66

IPO date2010-08-16

Latest filings

8-K2018-09-28 8-K2018-09-20 8-K2018-09-07 8-K2018-07-10 8-K2017-12-21 8-K2017-06-28 8-K2017-04-27 8-K2016-06-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.